4 research outputs found
Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters.
During human cytomegalovirus (HCMV) infection, the promoters for the classical NF-kappaB subunits (p65 and p105/p50) are transactivated. Previously, we demonstrated that the viral immediate-early (IE) proteins (IE1-72, IE2-55, and IE2-86) were involved in this upregulation. These viral factors alone, however, could not account for the entirety of the increased levels of transcription. Because one of the hallmarks of HCMV infection is the induction of cellular transcription factors, we hypothesized that one or more of these induced factors was also critical to the regulation of NF-kappaB during infection. Sp1 was one such factor that might be involved because p65 promoter activity was upregulated by Sp1 and both of the NF-kappaB subunit promoters are GC rich and contain Sp1 binding sites. Therefore, to detail the role that Sp1 plays in the regulation of NF-kappaB during infection, we initially examined Sp1 levels for changes during infection. HCMV infection resulted in increased Sp1 mRNA expression, protein levels, and DNA binding activity. Because both promoters were transactivated by Sp1, we reasoned that the upregulation of Sp1 played a role in p65 and p105/p50 promoter activity during infection. To address the specific role of Sp1 in p65 and p105/p50 promoter transactivation by HCMV, we mutated both promoters. These results demonstrated that the Sp1-specific DNA binding sites were involved in the virus-mediated transactivation. Last, to further dissect the role of HCMV in the Sp1-mediated induction of NF-kappaB, we examined the role that the viral IE genes played in Sp1 regulation. The IE gene products (IE1-72, IE2-55, and IE2-86) cooperated with Sp1 to increase promoter transactivation and physically interacted with Sp1. In addition, the IE2-86 product increased Sp1 DNA binding by possibly freeing up inactive Sp1. These data supported our hypothesis that Sp1 was involved in the upregulation of NF-kappaB during HCMV infection through the Sp1 binding sites in the p65 and p105/p50 promoters and additionally demonstrated a potential viral mechanism that might be responsible for the upregulation of Sp1 activity
Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization
Monocytes and macrophages constitute the first line of defense of the immune system
against external pathogens. Macrophages have a highly plastic phenotype depending on
environmental conditions; the extremes of this phenotypic spectrum are a pro-inflammatory
defensive role (M1 phenotype) and an anti-inflammatory tissue-repair one (M2 phenotype).
The Inhibitor of Apoptosis (IAP) proteins have important roles in the regulation of several cellular
processes, including innate and adaptive immunity. In this study we have analyzed the
differential expression of the IAPs, NAIP, cIAP1 and cIAP2, during macrophage differentiation
and polarization into M1 or M2. In polarized THP-1 cells and primary human macrophages,
NAIP is abundantly expressed in M2 macrophages, while cIAP1 and cIAP2 show
an inverse pattern of expression in polarized macrophages, with elevated expression levels
of cIAP1 in M2 and cIAP2 preferentially expressed in M1. Interestingly, treatment with the
IAP antagonist SMC-LCL161, induced the upregulation of NAIP in M2, the downregulation
of cIAP1 in M1 and M2 and an induction of cIAP2 in M1 macrophages.This work was supported by Universidad
de Granada, Plan Propio 2015;#P3B: FAM, VMC
(http://investigacion.ugr.es/pages/planpropio/2015/
resoluciones/p3b_def_28072015); Universidad
de Granada CEI BioTic;#CAEP2-84: VMC (http://
biotic.ugr.es/pages/resolucionprovisional
enseaanzapractica22demayo/!); and Canadian nstitutes of Health Research;#231421, #318176,
#361847: STB, ECL, RK (http://www.cihr-irsc.gc.
ca/e/193.html). The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript